A 'BOLD' experiment in defining the utility of fMRI in drug development.
Borsook
David
D
Imaging Consortium for Drug Development, Brain Imaging Center, McLean Hospital, Belmont, USA. dborsook@partners.org
Bleakman
David
D
Hargreaves
Richard
R
Upadhyay
Jaymin
J
Schmidt
Karl F
KF
Becerra
Lino
L
D001921:Brain / Q000187:drug effects* / Q000503:physiopathology*; D001927:Brain Diseases / Q000188:drug therapy* / Q000503:physiopathology*; D002986:Clinical Trials as Topic / Q000379:methods*; D004341:Drug Evaluation / Q000379:methods*; D006801:Humans; D008279:Magnetic Resonance Imaging / Q000379:methods*; D018696:Neuroprotective Agents / Q000008:administration & dosage*; D014481:United States
D018696:Neuroprotective Agents